Radius: EffRx Pharmaceuticals SA: EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO In The United States
EffRx Pharmaceuticals SA, a commercial-stage pharmaceutical company focused on the development and commercialization of musculoskeletal and rare diseases medications, today announced that it has s...
Read full article »
President & CEO
Kelly Martin
Radius is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of osteoporosis, cancer, and endocrine diseases.
Read more